Dose Intensity
Showing 1 - 25 of >10,000
Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+
Not yet recruiting
- Breast Cancer
- (no location specified)
Aug 21, 2023
Breast Cancer, Stage III Breast Cancer, Breast Cancer Female Trial in Boston (THRIVE, Health Education Support Program)
Not yet recruiting
- Breast Cancer
- +4 more
- THRIVE
- Health Education Support Program
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 8, 2022
Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Dose-Painted Intensity Modulated Radiotherapy
-
Dublin, IrelandSt Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023
Acute Myeloid Leukemia Trial in Copenhagen (Venetoclax)
Recruiting
- Acute Myeloid Leukemia
-
Copenhagen, DenmarkDepartment of Hematology, Rigshospitalet
Jun 21, 2022
Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)
Not yet recruiting
- Tumor, Solid
- RCMI in painting dose on histoscannographic mapping
- Standard pan-sinusal IMRT
-
Caen, France
- +2 more
Jul 5, 2023
Metabolic Syndrome Trial in Charlottesville (Low Intensity Exercise + Metformin, High Intensity Exercise + Metformin, Low
Active, not recruiting
- Metabolic Syndrome
- Low Intensity Exercise + Metformin
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Dec 6, 2022
Exercise, Ketosis Trial (Ketone monoester, Placebo)
Not yet recruiting
- Exercise
- Ketosis
- Ketone monoester
- Placebo
- (no location specified)
Dec 17, 2022
Breast Cancer Trial in France, Netherlands (high dose boost, boost)
Active, not recruiting
- Breast Cancer
- high dose boost
- boost
-
Besancon, France
- +17 more
Jan 20, 2022
Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +3 more
- Intensity Modulated Radiation Therapy
- +3 more
- (no location specified)
Jul 11, 2023
Prostate Cancer Trial in Milwaukee (Radiation Therapy)
Recruiting
- Prostate Cancer
- Radiation Therapy
-
Milwaukee, WisconsinFroedtert Hospital
Mar 8, 2022
Non Small Cell Lung Cancer Stage III Trial in Melbourne (Functionally adapted, dose escalated VMAT radiotherapy)
Completed
- Non Small Cell Lung Cancer Stage III
- Functionally adapted, dose escalated VMAT radiotherapy
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2022
Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (radiation, drug, other, procedure)
Recruiting
- Esophagus Cancer
- +2 more
- Intensity Modulated Radiation Therapy
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 6, 2022
Lung Cancer Metastatic, Renal Cell Carcinoma, Head Neck Cancer Trial in France (Reduced dose intensity of IO)
Recruiting
- Lung Cancer Metastatic
- +7 more
- Reduced dose intensity of IO
-
Angers, France
- +25 more
Jun 24, 2022
Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)
Recruiting
- Type 1 Diabetes
- ECP regular-intensity arm
- +2 more
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
Oct 28, 2022
Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and
Recruiting
- Sickle Cell Disease
- hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
- hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 5, 2022
Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation
Recruiting
- Acute Leukemia
- Myelodysplastic Syndrome
- Hematopoietic Cell Transplantation
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Esophageal Cancer Trial in Shanghai (high dose chemoradiotherapy)
Recruiting
- Esophageal Cancer
- high dose chemoradiotherapy
-
Shanghai, Shanghai, ChinaShanghai Genernal Hospital
Mar 17, 2021
Multiple Myeloma Trial in Hamburg (allogeneic HSCT)
Completed
- Multiple Myeloma
- allogeneic HSCT
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 1, 2022
Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute
Not yet recruiting
- Peripheral Blood Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Melphalan
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Head and Neck Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab, Cisplatin, IMRT)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 15, 2022
Solid Tumor, Adult Trial in Pulau Pinang (Pharmacist-led Oral Chemo Care Program (POCCP))
Active, not recruiting
- Solid Tumor, Adult
- Pharmacist-led Oral Chemo Care Program (POCCP)
-
Pulau Pinang, MalaysiaHospital Pulau Pinang
Mar 5, 2021
Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)
Active, not recruiting
- Head and Neck Cancer
- Locally Advanced
- Palbociclib
- +2 more
-
Bangkok, ThailandFaculty of Medicine, Ramathibodi Hospital
Sep 19, 2022
Mild Cognitive Impairment Trial in Tucson (Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (Low Intensity))
Not yet recruiting
- Mild Cognitive Impairment
- Transcranial Magnetic Stimulation
- Transcranial Magnetic Stimulation (Low Intensity)
-
Tucson, ArizonaBioscience Research Laboratory
Aug 22, 2022
Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)
Recruiting
- Recurrent Glioblastoma
- Intensity Modulated Proton Therapy (IMPT)
- Bevacizumab
-
Miami, FloridaUniversity of Miami
Sep 30, 2022